Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000899243-21-003472

Options or other derivatives

  • VP Finance & Accounting acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Thomson Peter G. VP Finance & Accounting 2021-01-25 Grant or award · Stock Option (right to buy) +40,000 40,000 D
Loading xslF345X03/doc4.xml…